D11
OPIOID ANTAGONIST ADMINISTRATION POLICY
Approved: 9/25/2019
I. PURPOSE
The purpose of this policy is to establish guidelines and procedures governing the administration and use of any Opioid Antagonist by the Ypsilanti District Library (“Library”).
II. DEFINITIONS
As used in this Policy:
A. Act. The “Act” shall mean the Administration of Opioid Antagonist Act, 2019 PA 39.
B. Employee or agent. “Employee or Agent” means any of the following:
- An individual who is employed by, or under contract with, the Library.
- An individual who serves on the Library Board of the Library.
- An individual who volunteers at the Library.
C. Gross Negligence. “Gross negligence” means conduct so reckless as to demonstrate a substantial lack of concern for whether an injury results.
D. Library. “Library” shall mean the Ypsilanti District Library.
E. Opioid Antagonist. “Opioid Antagonist” means the nasal spray version of Naloxone for the purposes of this Policy.
F. Opioid-related Overdose. “Opioid-related Overdose” means a condition, including, but not limited to, extreme physical illness, decreased level of consciousness, respiratory depression, coma, or death, that results from the consumption or use of an opioid or another substance with which an opioid was combined or that a reasonable person would believe to be an opioid-related overdose that requires medical assistance.
III. POLICY
A. Provision of Opioid Antagonist. As permitted by the Act, the Library shall provide and maintain on-site at the Library (including any of its branches) Opioid Antagonists to treat a case of suspected Opioid-related Overdose in the Library or on Library Property.
B. Provision of Opioid Antagonist. The Library may purchase and possess an Opioid Antagonist for the purpose of implementing the Act. The Opioid Agent shall be stored in a secure location in each branch. Such locations shall be determined by the Director. All Library Employees or Agents trained to administer the Opioid Antagonist shall be informed of the location of the Opioid Antagonist.
C. Distribution and Administration of Opioid Antagonist. An Employee or Agent may possess an Opioid Antagonist distributed to that Employee or Agent and may administer that Opioid Antagonist to an individual if both of the following apply:
- The Employee or Agent has been trained in the proper administration of that Opioid Antagonist; and
- The Employee or Agent has reason to believe that the individual is experiencing an Opioid-Related Overdose.
IV. TRAINING
Employees or Agents of the Library who volunteer shall be trained in the proper administration of an Opioid Antagonist. The Library Director shall determine who is trained. The training shall be conducted by any person or organization that is accredited to train for the administration and use of an Opioid Antagonist. The Library shall attach the protocol for the administration of the Opioid Antagonist as Exhibit A to this Policy. After the initial training, the Library Director shall determine when supplemental or additional training should occur.
V. PROCUREMENT AND STORAGE OF OPIOID ANTAGONIST
A. Procurement. The Library Director or designee will be responsible for the procurement of the Opioid Antagonist. The Library Director shall replace the supply as needed and shall monitor the supply for expiration dates.
B. Supplies. At minimum, the Library shall have the following supplies:
- At least 2 doses of the Opioid Antagonist on each floor open to the public at each branch
- Gloves
- Face Mask
- Step-by-Step Instructions regarding the administration
C. Storage. The following shall apply to the storage of the Opioid Antagonist.
- Opioid Antagonist will be clearly marked and stored in an accessible place at the discretion of the Director. The Director or designee will ensure that all other relevant staff are aware of the Opioid Antagonist storage location.
- Opioid Antagonist will be stored in accordance with manufacturer’s instructions to avoid extreme cold, heat, and direct sunlight.
- Inspection of the Opioid Antagonist shall be conducted regularly, including checking the expiration date found on box.
VI. USE OF OPIOID ANTAGONIST
A. 911. Any Library Employee or Agent shall call 911 immediately.
B. Use Protocol. After calling 911 and if necessary in case of a suspected Opioid-related Overdose, the Library Employee or agent may administer the Opioid Antagonist. If administered, the Library Director or other trained Employee or Agent shall follow the protocols outlined in the Opioid Antagonist Training (See attached) to prepare and administer the Opioid Antagonist. The protocol for the administration of the Opioid Antagonist is attached as Exhibit A to this Policy and is considered incorporated as part of this Policy. The protocol shall be reviewed and updated if required after additional training.
C. Incident Report. The Library Employee or Agent who calls 911 and/or administers the Opioid Antagonist shall complete an incident report in the form approved by the Library Director. The report shall not be released unless in conformance with the Library Privacy Act or required by law.
VII. IMMUNITY
A. Civil Liability. As stated in the Act, the Library and an Employee or Agent that possesses or in good faith administers an Opioid Antagonist as provided by law is immune from civil liability for injuries or damages arising out of the administration of that Opioid Antagonist to an individual under the Act if the conduct does not amount to Gross Negligence that is the proximate cause of the injury or damage.
B. Criminal Liability. The Library and an Employee or Agent of the Library that possesses or in good faith administers an opioid antagonist is not subject to criminal prosecution for purchasing, possessing, or distributing an Opioid Antagonist under the Act or for administering an Opioid Antagonist to an individual under the Act.
C. Immunity by Law. The immunity provided by the Act is in addition to any immunity otherwise provided by law.